Page last updated: 2024-12-05

mesityl oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

mesityl oxide: solvent for extraction of nitrocellulose, many resins, & tellurium; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8858
CHEMBL ID3185916
CHEBI ID89993
MeSH IDM0052150

Synonyms (97)

Synonym
4-methyl-pent-3-en-2-one
mesityl oxide
isopropylideneacetone
methyl 2,2-dimethylvinyl ketone
4-methyl-3-penten-2-on(dutch, german)
2-methyl-2-penten-4-one
mesityloxyde
nsc-38717
nsc38717
mesityloxid
wln: 1y1 & u1v1
acetone, isopropylidene-
ossido di mesitile
methyl 2-methyl-1-propenyl ketone
4-methyl-3-penten-2-one
4-metil-3-penten-2-one
4-methyl-3-pentene-2-one
oxyde de mesityle
isobutenyl methyl ketone
methyl isobutenyl ketone
3-isohexen-2-one
fema number 3368
hsdb 1195
mesityl oxide [un1229] [flammable liquid]
4-methyl-3-penten-2-on [dutch, german]
2-methyl-4-oxo-2-pentene
caswell no. 547
mesityloxyde [dutch]
4-metil-3-penten-2-one [italian]
einecs 205-502-5
nsc 38717
isopropylidene acetone
mesityloxid [german]
2,2-dimethylvinyl methyl ketone
fema no. 3368
brn 1361550
epa pesticide chemical code 052401
oxyde de mesityle [french]
2-methyl-2-pentenone-4
un1229
ossido di mesitile [italian]
ai3-07702
3-penten,2-one,4-methyl mesityloxide
3-penten-2-one, 4-methyl-
141-79-7
inchi=1/c6h10o/c1-5(2)4-6(3)7/h4h,1-3h
4-methylpent-3-en-2-one
4-methyl-3-penten-2-one, 90%
mesityl oxide, technical grade, 90%
AKOS000118892
M0069
M1340
A807813
NCGC00249161-01
LMFA12000030
cas-141-79-7
dtxcid209170
tox21_303606
dtxsid1029170 ,
NCGC00257514-01
tox21_202080
NCGC00259629-01
STL146350
mesityl oxide [un1229] [flammable liquid]
unii-77lac84669
ec 205-502-5
4-methyl-3-penten-2-on
77lac84669 ,
FT-0628235
4-methyl-3-pentene-2-one [fhfi]
mesityl oxide [hsdb]
mesityl oxide [mi]
teicoplanin impurity a [ep impurity]
cilastatin sodium impurity d [ep impurity]
Q-201356
(ch3)2c=chc(=o)ch3
un 1229
2-methylpent-2-en-4-one
chebi:89993 ,
CHEMBL3185916
4-methyl-3-penten-2-one, 9ci
mfcd00008900
mesityl oxide, 90%, remainder 4-methyl-4-penten-2-one
4-methyl-3-penten-2-one, analytical reference material
mesityl oxide, pharmaceutical secondary standard; certified reference material
mesityl oxide, suitable for neutral marker for measuring electroosmotic flow (eof), ~98%
mesityl oxide, european pharmacopoeia (ep) reference standard
fema 3368
4-methyl-3-penten-2-one (mesityl oxide)
1-methylpent-2-en-4-one
3-penten,2-one,4-methyl mesityloxide
mesityloxid(german)
isopropylidene-acetone
Q425668
AMY23356
EN300-21333
4-methylpent-3-en-2-one; mesityl oxide; cilastatin sodium imp. d (ep)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
olefinic compoundAny organic molecular entity that contains at least one C=C bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency2.88030.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency1.94960.000221.22318,912.5098AID743036
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency28.58830.001022.650876.6163AID1224838; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency28.30750.003041.611522,387.1992AID1159552
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.25480.000229.305416,493.5996AID743079
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency4.32770.001723.839378.1014AID743083
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency0.08710.057821.109761.2679AID1159526
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1469819Glutathione reactivity of the compound in DMSO and phosphate buffer assessed as second order rate constant for adduct formation2017Journal of medicinal chemistry, 02-09, Volume: 60, Issue:3
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (18.18)18.7374
1990's1 (4.55)18.2507
2000's8 (36.36)29.6817
2010's7 (31.82)24.3611
2020's2 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 72.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index72.16 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index119.21 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (72.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]